Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fampiridine for optic nerve imaging in anterior ischemic optic neuropathy
IRCT20151123025202N35Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of fampridine in anterior ischemic optic neuropathy (AION), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Change in optic nerve imaging parameters. Started Mar 2024; status: completed.
02
Drugs
fampridine
03
Conditions
anterior ischemic optic neuropathy (AION)
Beyond the preview
Go deeper on IRCT20151123025202N35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151123025202N35.